![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1489, 2005-01, pp. : 8-8
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Quadrivalent HPV vaccine may prevent cervical cancer
Inpharma, Vol. 1, Iss. 1467, 2004-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
HPV vaccine recombinant quadrivalent: safety concerns
Reactions Weekly, Vol. 1, Iss. 1139, 2007-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Meningococcal vaccine immunogenic with DTaP, HPV
Inpharma, Vol. 1, Iss. 1664, 2008-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Quadrivalent HPV L1 VLP vaccine prevents vulval, vaginal lesions
Inpharma, Vol. 1, Iss. 1589, 2007-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Virosome-adjuvanted flu vaccine safe and highly immunogenic
Inpharma, Vol. 1, Iss. 1435, 2004-01 ,pp. :